Table 1.
Year | Name | Sequence | Source | Activity 2 | Ref. |
---|---|---|---|---|---|
1922 | Lysozyme | KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV | saliva, tears, intestine | G, F | [20] |
1985 | α-Defensin HNP-1 |
ACYCRIPACIAGERRYGTCIYQGRLWAFCC | Neutrophils, bone marrow | G, V, F, P, C | [21] |
1985 | α-Defensin HNP-2 |
CYCRIPACIAGERRYGTCIYQGRLWAFCC | Neutrophils, bone marrow | G, V, F, C | [21] |
1985 | α-Defensin HNP-3 |
DCYCRIPACIAGERRYGTCIYQGRLWAFCC | Neutrophils, bone marrow | G, V, F, C | [21] |
1988 | Histatin 1 | DSHEKRHHGYRRKFHEKHHSHREFPFYGDYGSNYLYDN | saliva | F | [22] |
1988 | Histatin 3 | DSHAKRHHGYKRKFHEKHHSHRGYRSNYLYDN | saliva | G, F | [22] |
1989 | α-Defensin HNP-4 | VCSCRLVFCRRTELRVGNCLIGGVSFTYCCTRV | neutrophils | G, V, F | [23] |
1990 | RNase 2 | KPPQFTWAQWFETQHINMTSQQCTNAMQVINNYQRRCKNQNTFLLTTFANVVNVCGNPNMTCPSNKTRKNCHHSGSQVPLIHCNLTTPSPQNISNCRYAQTPANMFYIVACDNRDQRRDPPQYPVVPVHLDRII | eosinophils | V, P | [24] |
1990 | RNase 3 (Eosinophil cationic protein, ECP) | RPPQFTRAQWFAIQHISLNPPRCTIAMRAINNYRWRCKNQNTFLRTTFANVVNVCGNQSIRCPHNRTLNNCHRSRFRVPLLHCDLINPGAQNISNCTYADRPGRRFYVVACDNRDPRDSPRYPVVPVHLDTTI | neutrophils | G, V, P | [24] |
1992 | α-Defensin HD-5 |
ATCYCRTGRCATRESLSGVCEISGRLYRLCCR | Paneth cells/intestine, female reproductive system | G, V, F | [25] |
1993 | α-Defensin HD-6 |
AFTCHCRRSCYSTEYSYGTCTVMGINHRFCCL | Paneth cells/intestine | V, F | [26] |
1995 | β-Defensin hBD-1 |
DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK | Kidney, Skin, salivary glands | G, F, C | [27] |
1995 | Cathelicidin LL-37 |
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | neutrophils; skin | G, V, F, P, C | [28,29,30] |
1997 | β-Defensin hBD-2 | GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP | skin, lung, epithelia, uterus, salivary glands | G, V, F | [31] |
1998 | Granulysin | GRDYRTCLTIVQKLKKMVDKPTQRSVSNAATRVCRTGRSRWRDVCRNFMRRYQSRVTQGLVAGETAQQICEDLR | cytolytic T and NK cells | G, F, P, C | [32] |
1999 | Ubiquicidin | KVHGSLARAGKVRGQTPKVAKQEKKKKKTGRAKRRMQYNRRFVNVVPTFGKKKGPNANS | macrophages | G | [33] |
2000 | Thrombocidin-1 (TC-1) | AELRCMCIKTTSGIHPKNIQSLEVIGKGTHCNQVEVIATLKDGRKICLDPDAPRIKKIVQKKLAGDES | human blood platelets | G, F | [34] |
2000 | Hepcidin 25 (LEAP-1) | DTHFPICIFCCGCCHRSKCGMCCKT | plasma, Urine/Liver | G, F | [35] |
2000 | Neuropeptide α-MSH | SYSMEHFRWGKPV | brain | G+, V, F | [36] |
2001 | β-Defensin hBD-3 | GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK | Skin, salivary glands | G, V, F | [37] |
2001 | β-Defensin hBD-4 | FELDRICGYGTARCRKKCRSQEYRIGRCPNTYACCLRKWDESLLNRTKP | testis, lung, kidney, neutrophils | G | [38] |
2001 | Dermcidin | SSLLEKGLDGAKKAVGGLGKLGKDAVEDLESVGKGAVHDVKDVLDSV | eccrine sweat/skin | G, F | [39] |
2002 | RNase 7 | KPKGMTSSQWFKIQHMQPSPQACNSAMKNINKHTKRCKDLNTFLHEPFSSVAATCQTPKIACKNGDKNCHQSHGAVSLTMCKLTSGKYPNCRYKEKRQNKSYVVACKPPQKKDSQQFHLVPVHLDRVL | urinary tract; respiratory tract; skin | G, F | [40] |
2003 | RNase 5 (angiogenin) | QDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGPTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRPRP | Liver, skin, intestine | G+, F | [41] |
2003 | Chemokine CCL20 |
SNFDCCLGYTDRILHPKFIVGFTRQLANEGCDINAIIFHTKKKLSVCANPKQTWVKYIVRLLSKKVKNM | skin | G, F, P | [42] |
2003 | Chemokine CXCL9 |
TPVVRKGRCSCISTNQGTIHLQSLKDLKQFAPSPSCEKIEIIATLKNGVQTCLNPDSADVKELIKKWEKQVSQKKKQKNGKKHQKKKVLKVRKSQRSRQKKTT | blood | G, P | [42] |
2005 | Psoriasin (S100A7) | MSNTQAERSIIGMIDMFHKYTRRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGDIATDYHKQSHGAAPCSGGSQ | Skin, salivary glands, breast | G- | [43] |
2006 | RegIIIα | EEPQRELPSARIRCPKGSKAYGSHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGNSYSYVWIGLHDPTQGTEPNGEGWEWSSSDVMNYFAWERNPSTISSPGHCASLSRSTAFLRWKDYNCNVRLPYVCKFTD | intestine | G+ | [44] |
2008 | Substance P | RPKPQQFFGLM | the nervous system | G, F | [45] |
2008 | Drosomycin-like defensin (DLD) | CLAGRLDKQCTCRRSQPSRRSGHEVGRPSPHCGPSRQCGCHMD | oral epithelial cells, skin | F | [46] |
2009 | Elafin | AQEPVKGPVSTKPGSCPIILIRCAMLNPPNRCLKDTDCPGIKKCCEGSCGMACFVPQ | γδ T cells | G, F, V | [47] |
2010 | β-amyloid peptide 1-42 | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVI | brain | G, F | [48] |
2011 | Chemerin | ELTEAQRRGLQVALEEFHKHPPVQWAFQETSVESAVDTPFPAGIFVRLEFKLQQTSCRKRDWKKPECKVRPNGRKRKCLACIKLGSEDKVLGRLVHCPIETQVLREAEEHQETQCLRVQRAGEDPHSFYFPGQFAFS | skin | G, F | [49] |
2012 | Amylin | KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY | pancreatic β-cells | G | [50] |
2012 | KDAMP | RAIGGGLSSVGGGSSTIKY | eyes | G- | [51] |
2013 | DEFB114 | DRCTKRYGRCKRDCLESEKQIDICSLPRKICCTEKLYEEDDMF | epididymis | G, F | [19] |
1 Data from the APD [7,8]. For a complete list of human AMPs, please visit the APD website (http://aps.unmc.edu/AP) and search in the name field using “human”. 2 In the APD, antimicrobial activities against different types of microbes are annotated as below: G, bacteria; G+, Gram-positive bacteria only; G-, Gram-negative bacteria only; F, fungi; V, viruses; P, parasites; C, cancer cells.